Prevalence and Characteristics of Gastrointestinal Symptoms in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the United States: A Multicenter Cohort Study
Redd, Walker D.
Zhou, Joyce C.
Hathorn, Kelly E.
Thompson, Christopher C.
Chan, Walter W.
MetadataShow full item record
Summary in foreign language
Although anecdotally coronavirus disease 2019 (COVID-19) presents most commonly with respiratory symptoms, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) obtains cellular entry via the widely expressed angiotensin-converting enzyme 2 (ACE2) receptors, thus increasing the risk of not only respiratory but also alimentary tract involvement.1, 2, 3 Early reports from China have described gastrointestinal symptoms in as many as half of patients diagnosed with COVID-19; however, data regarding the potential gastrointestinal implications of COVID-19 among the US patient population remain limited.4, 5, 6 Therefore, we aimed to systematically characterize the prevalence and features of gastrointestinal manifestations associated with SARS-CoV-2 infection and evaluate gastrointestinal-specific health outcomes among a cohort of US adults.
Link to resourcehttps://www.gastrojournal.org/article/S0016-5085(20)30564-3/fulltext?referrer=https%3A%2F%2Fwww.google.com%2Furl%3Fsa%3DD%26q%3Dhttps%3A%2F%2Fdoi.org%2F10.1053%2Fj.gastro.2020.04.045%26ust%3D1596058140000000%26usg%3DAOvVaw2K8TysoAiZgLVfh84Fxo2y%26hl%3Des#secsectitle0010
Estadísticas Google Analytics
Respuesta Comentario Repositorio Expeditio
Gracias por tomarse el tiempo para darnos su opinión.